Product Description
Matriks Biotek Shikari® Shikari® (S-ATPAL) w/confirmation - Palivizumab (Synagis® ) (Antibody screening - Quantitative) ELISA Kit
Enzyme immunoassay for the quantitative determination (screening) of antibodies to Palivizumab (Synagis®) in serum and plasma with confirmation.
This kit has been especially developed for the quantitative determination of antibodies to palivizumab in serum and plasma samples.
Specifications:
| Required Volume (µl) | 5 |
| Total Time (min) | 140 |
| Sample | Serum, plasma |
| Sample Number | 96 |
| Detection Limit (ng/mL) | 18.75 |
| Spike Recovery (%) | Between 85-115 |
| Shelf Life (months) | 12 |
Standard Lead time : 3-4 Weeks (subject to change)
Documentation
Download sample IFU
Download sample MSDS
Please note that the documentation provided is for reference use only. For the most updated version, please contact us.
For Research Use Only
Manufactured by Matriks Biotek Co.
| Questions about this product? Ready to place an order? Email us at orders@iwai-chem.com or give us a call: (650) 486-1541 |
